Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.40 |
7.14 |
-63.29 |
4 |
9 |
-1 |
139 |
431.428 |
5 |
↓
|
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
2 |
0.38 |
Binding ≤ 10μM |
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.39 |
Binding ≤ 10μM |
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.39 |
Binding ≤ 10μM |
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.37 |
Binding ≤ 10μM |
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.39 |
Binding ≤ 10μM |
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.39 |
Binding ≤ 10μM |
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.39 |
Binding ≤ 10μM |
Z100405-1-O |
MV4-11 (Myeloid Leukemia Cells) (cluster #1 Of 1), Other |
Other |
17 |
0.34 |
Functional ≤ 10μM |
ChEMBL Target Annotations
Uniprot |
Swissprot |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
PGFRA_HUMAN |
P16234
|
Platelet-derived Growth Factor Receptor Alpha, Human |
0.98 |
0.39 |
Binding ≤ 1μM
|
AURKA_HUMAN |
O14965
|
Serine/threonine-protein Kinase Aurora-A, Human |
2.09 |
0.38 |
Binding ≤ 1μM
|
AURKB_HUMAN |
Q96GD4
|
Serine/threonine-protein Kinase Aurora-B, Human |
1.19 |
0.39 |
Binding ≤ 1μM
|
KIT_HUMAN |
P10721
|
Stem Cell Growth Factor Receptor, Human |
3.1 |
0.37 |
Binding ≤ 1μM
|
FLT3_HUMAN |
P36888
|
Tyrosine-protein Kinase Receptor FLT3, Human |
0.5 |
0.41 |
Binding ≤ 1μM
|
VGFR2_HUMAN |
P35968
|
Vascular Endothelial Growth Factor Receptor 2, Human |
0.5 |
0.41 |
Binding ≤ 1μM
|
VGFR3_HUMAN |
P35916
|
Vascular Endothelial Growth Factor Receptor 3, Human |
0.8 |
0.40 |
Binding ≤ 1μM
|
PGFRA_HUMAN |
P16234
|
Platelet-derived Growth Factor Receptor Alpha, Human |
0.98 |
0.39 |
Binding ≤ 10μM
|
AURKA_HUMAN |
O14965
|
Serine/threonine-protein Kinase Aurora-A, Human |
2.09 |
0.38 |
Binding ≤ 10μM
|
AURKB_HUMAN |
Q96GD4
|
Serine/threonine-protein Kinase Aurora-B, Human |
1.19 |
0.39 |
Binding ≤ 10μM
|
KIT_HUMAN |
P10721
|
Stem Cell Growth Factor Receptor, Human |
3.1 |
0.37 |
Binding ≤ 10μM
|
FLT3_HUMAN |
P36888
|
Tyrosine-protein Kinase Receptor FLT3, Human |
0.5 |
0.41 |
Binding ≤ 10μM
|
VGFR2_HUMAN |
P35968
|
Vascular Endothelial Growth Factor Receptor 2, Human |
0.5 |
0.41 |
Binding ≤ 10μM
|
VGFR3_HUMAN |
P35916
|
Vascular Endothelial Growth Factor Receptor 3, Human |
0.8 |
0.40 |
Binding ≤ 10μM
|
Z100405 |
Z100405
|
MV4-11 (Myeloid Leukemia Cells) |
17 |
0.34 |
Functional ≤ 10μM
|
Reactome Annotations from Targets (via Uniprot)
Description |
Species |
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins |
|
Constitutive PI3K/AKT Signaling in Cancer |
|
Downstream signal transduction |
|
EPHA-mediated growth cone collapse |
|
Integrin cell surface interactions |
|
Mitotic Prometaphase |
|
Neurophilin interactions with VEGF and VEGFR |
|
PIP3 activates AKT signaling |
|
Regulation of KIT signaling |
|
Regulation of PLK1 Activity at G2/M Transition |
|
Resolution of Sister Chromatid Cohesion |
|
Separation of Sister Chromatids |
|
Signaling by PDGF |
|
Signaling by SCF-KIT |
|
VEGF binds to VEGFR leading to receptor dimerization |
|
VEGFA-VEGFR2 Pathway |
|
VEGFR2 mediated cell proliferation |
|
No pre-computed analogs available. Try a structural similarity search.